应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARCT Arcturus Therapeutics Ltd.
休市中 08-23 16:00:00 EDT
21.99
+0.52
+2.42%
盘后
22.25
+0.26
+1.18%
19:18 EDT
最高
22.25
最低
21.35
成交量
24.80万
今开
21.83
昨收
21.47
日振幅
4.22%
总市值
5.95亿
流通市值
5.44亿
总股本
2,704万
成交额
543.43万
换手率
1.00%
流通股本
2,474万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arcturus Therapeutics Holdings Inc.盘中异动 下午盘快速拉升5.05%报21.22美元
自选股智能写手 · 08-20
Arcturus Therapeutics Holdings Inc.盘中异动 下午盘快速拉升5.05%报21.22美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.10%
自选股智能写手 · 08-15
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.10%
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.07%报19.91美元
自选股智能写手 · 08-14
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.07%报19.91美元
Arcturus Therapeutics Holdings Inc.2024财年第二财季实现净利润-17.22百万美元,同比增加67.23%
自选股智能写手 · 08-11
Arcturus Therapeutics Holdings Inc.2024财年第二财季实现净利润-17.22百万美元,同比增加67.23%
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%报17.85美元
自选股智能写手 · 08-10
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%报17.85美元
美国研究综述-安进、Atkore、MoneyLion
Reuters · 08-08
美国研究综述-安进、Atkore、MoneyLion
Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.24%
自选股智能写手 · 08-07
Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.24%
坎托菲茨杰拉德公司:重申Arcturus Therapeutics(ARCT.US)增持评级。
智通财经 · 08-06
坎托菲茨杰拉德公司:重申Arcturus Therapeutics(ARCT.US)增持评级。
Arcturus Therapeutics Holdings Inc.股价拉升13.42% 市值涨8145.44万美元
自选股智能写手 · 08-06
Arcturus Therapeutics Holdings Inc.股价拉升13.42% 市值涨8145.44万美元
Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌7.64%报18.98美元
自选股智能写手 · 08-05
Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌7.64%报18.98美元
Arcturus Therapeutics Holdings Inc 预计每股亏损 1.60 美元 - 财报前瞻
Reuters · 08-03
Arcturus Therapeutics Holdings Inc 预计每股亏损 1.60 美元 - 财报前瞻
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌6.21%报20.24美元
自选股智能写手 · 08-02
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌6.21%报20.24美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.05%报24.14美元
自选股智能写手 · 07-26
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.05%报24.14美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 07-25
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 07-17
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.00%报24.55美元
自选股智能写手 · 07-16
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.00%报24.55美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅跳水5.20%
自选股智能写手 · 07-02
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅跳水5.20%
HC Wainwright & Co.:重申Arcturus Therapeutics(ARCT.US)评级,由买入调整至买入评级, 目标价由60.
智通财经 · 07-02
HC Wainwright & Co.:重申Arcturus Therapeutics(ARCT.US)评级,由买入调整至买入评级, 目标价由60.
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌5.10%
自选股智能写手 · 06-26
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌5.10%
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.39%报29.33美元
自选股智能写手 · 06-17
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.39%报29.33美元
加载更多
公司概况
公司名称:
Arcturus Therapeutics Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arcturus Therapeutics Holdings Inc.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。
发行价格:
--
{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":21.99,"timestamp":1724443200000,"preClose":21.47,"halted":0,"volume":248042,"hourTrading":{"tag":"盘后","latestPrice":22.25,"preClose":21.99,"latestTime":"19:18 EDT","volume":7693,"amount":169226.76,"timestamp":1724455133402},"delay":0,"floatShares":24744047,"shares":27042246,"eps":-2.687716,"marketStatus":"休市中","marketStatusCode":7,"change":0.52,"latestTime":"08-23 16:00:00 EDT","open":21.83,"high":22.25,"low":21.345,"amount":5434282.72624,"amplitude":0.042152,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.687716,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":21.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":22.13,"preClose":21.47,"latestTime":"09:28 EDT","volume":78,"amount":1704.150084,"timestamp":1724419685167},"postHourTrading":{"tag":"盘后","latestPrice":22.25,"preClose":21.99,"latestTime":"19:18 EDT","volume":7693,"amount":169226.76,"timestamp":1724455133402},"volumeRatio":0.7525007310913113,"impliedVol":0.5933,"impliedVolPercentile":0.0397},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"2460050132","title":"Arcturus Therapeutics Holdings Inc.盘中异动 下午盘快速拉升5.05%报21.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460050132","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460050132?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:05","pubTimestamp":1724090745,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时05分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速拉升5.05%。截至发稿,该股报21.22美元/股,成交量18.4542万股,换手率0.68%,振幅4.61%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.27%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002054698e35675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002054698e35675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2459972479","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459972479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459972479?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:03","pubTimestamp":1723734237,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时03分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速上涨5.10%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为6313.22%、2040.77%、570.62%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.,振幅分别为103.98%、79.83%、70.46%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230357a1d47491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230357a1d47491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2459131904","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.07%报19.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459131904","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459131904?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:52","pubTimestamp":1723578753,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时52分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价大幅上涨5.07%。截至发稿,该股报19.91美元/股,成交量32.5083万股,换手率1.20%,振幅6.46%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.05%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035234a1d434ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035234a1d434ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2458682672","title":"Arcturus Therapeutics Holdings Inc.2024财年第二财季实现净利润-17.22百万美元,同比增加67.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682672","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682672?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:20","pubTimestamp":1723306851,"startTime":"0","endTime":"0","summary":"8月11日,Arcturus Therapeutics Holdings Inc.公布财报,公告显示公司2024财年第二财季净利润为-17.22百万美元,同比增加67.23%;其中营业收入为45.98百万美元,同比增加380.46%,每股基本收益为-0.64美元。机构评级:截至2024年8月11日,当前有8家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测,其中目标均价为72.88美元,其中最低目标价为44.00美元,最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110021029f204b7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110021029f204b7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2458513075","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%报17.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458513075","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458513075?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:03","pubTimestamp":1723219392,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时03分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价大幅跳水5.00%。截至发稿,该股报17.85美元/股,成交量15.1802万股,换手率0.56%,振幅8.68%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.07%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810000312968257b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810000312968257b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2457821758","title":"美国研究综述-安进、Atkore、MoneyLion","url":"https://stock-news.laohu8.com/highlight/detail?id=2457821758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457821758?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:34","pubTimestamp":1723048497,"startTime":"0","endTime":"0","summary":" 路透8月7日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括安进公司、Atkore公司和MoneyLion公司。要闻 * 安进公司 :加拿大皇家银行将目标价从332美元上调至362美元 * Atkore Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。* MoneyLion :Needham将目标价从100美元下调至70美元 * Progyny Inc :BTIG将其评级从 \"买入 \"下调至 \"中性\"。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABL","AVNT","IE00B19Z4B17.USD","AMWL","ANAB","AZPN","AMGN","ARCT","ADTN","AZTA","AHCO","BK4548","ADUS","AXON","CAR","ASH","LU1023059063.AUD","AIRG","IE00BJT1NW94.SGD","AGL","BK4109","ASPI","ARMK","BBWI","BK4006","IE0031619046.USD","LU0122379950.USD","ALAB","AVB","LU1989773731.SGD","AMH","BEAM","GOLF","AESI","BWIN","AEE","AEP","ALGT","ACM","BAX","ATKR","ACAD","ATI","CELH","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","ACA","IE00B3S45H60.SGD","ALIT"],"gpt_icon":1},{"id":"2457584293","title":"Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457584293","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457584293?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:56","pubTimestamp":1723039008,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时56分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速上涨5.24%。截至发稿,该股报20.87美元/股,成交量14.1857万股,换手率0.52%,振幅4.08%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.36%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721564896824cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721564896824cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2457271660","title":"坎托菲茨杰拉德公司:重申Arcturus Therapeutics(ARCT.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457271660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457271660?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:23","pubTimestamp":1722957787,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2457023620","title":"Arcturus Therapeutics Holdings Inc.股价拉升13.42% 市值涨8145.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023620","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023620?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951106,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价大幅上涨13.42%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为690.53%、274.27%、201.49%,振幅较大的相关个股有Vbi Vaccines, Inc.、Moleculin Biotech, Inc.、Cingulate Inc.,振幅分别为47.69%、11.20%、10.37%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131469582cb8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131469582cb8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2457775374","title":"Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌7.64%报18.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775374","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775374?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865083,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速跳水7.64%。截至发稿,该股报18.98美元/股,成交量2.7606万股,换手率0.10%,振幅2.02%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.94%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138039f1072ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138039f1072ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2456260447","title":"Arcturus Therapeutics Holdings Inc 预计每股亏损 1.60 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456260447","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456260447?lang=zh_cn&edition=full","pubTime":"2024-08-03 08:12","pubTimestamp":1722643940,"startTime":"0","endTime":"0","summary":" * Arcturus Therapeutics Holdings Inc 将于8月5日公布截至2024年6月30日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,7位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的1052万美元增长106.3%,达到2169.6万美元。* LSEG 分析师对 Arcturus Therapeutics Holdings Inc 的平均预期是每股亏损 1.19 美元。* 华尔街对 Arcturus Therapeutics Holdings Inc 的 12 个月目标价中位数为 71.00 美元,高于其上次收盘价 20.55 美元。8月3日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2456289100","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌6.21%报20.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456289100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456289100?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605473,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速跳水6.21%。截至发稿,该股报20.24美元/股,成交量6608股,换手率0.02%,振幅0.00%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213114941fd886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213114941fd886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"gpt_icon":0},{"id":"2454232375","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.05%报24.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454232375","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454232375?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:45","pubTimestamp":1722001528,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时45分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速拉升5.05%。截至发稿,该股报24.14美元/股,成交量1.8334万股,换手率0.07%,振幅3.34%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214528aefbb228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214528aefbb228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2454960837","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454960837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454960837?lang=zh_cn&edition=full","pubTime":"2024-07-25 03:26","pubTimestamp":1721849194,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日03时26分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速下挫5.00%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大,Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃,换手率分别为9255.35%、1574.01%、731.43%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ,振幅分别为211.54%、99.60%、75.86%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250326349681fe73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250326349681fe73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2452658381","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452658381","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452658381?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:38","pubTimestamp":1721227115,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时38分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速跳水5.00%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.83%。其相关个股中,Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为2499.72%、1208.82%、259.12%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.,振幅分别为76.39%、43.75%、31.25%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717223835aefa27a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717223835aefa27a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2451913673","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.00%报24.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451913673","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451913673?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:50","pubTimestamp":1721137847,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时50分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速上涨5.00%。截至发稿,该股报24.55美元/股,成交量2.2645万股,换手率0.08%,振幅3.17%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215047af9299b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215047af9299b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2448150180","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448150180","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448150180?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:04","pubTimestamp":1719929055,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时04分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速下跌5.20%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.75%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。消息层面,截至22时04分,《H.C. Wainwright维持Arcturus Therapeutics买入评级,维持目标价60美元》资讯为影响Arcturus Therapeutics Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702220415af903498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702220415af903498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2448397391","title":"HC Wainwright & Co.:重申Arcturus Therapeutics(ARCT.US)评级,由买入调整至买入评级, 目标价由60.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448397391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448397391?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:26","pubTimestamp":1719916005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2446940353","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446940353","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446940353?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:37","pubTimestamp":1719412675,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时37分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速下跌5.10%。截至发稿,该股报24.93美元/股,成交量5.8186万股,换手率0.22%,振幅4.68%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.90%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223756941f16c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223756941f16c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"gpt_icon":0},{"id":"2444160682","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.39%报29.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444160682","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444160682?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:43","pubTimestamp":1718631828,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时43分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速下跌5.39%。截至发稿,该股报29.33美元/股,成交量3.8315万股,换手率0.14%,振幅2.55%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214348af8de342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214348af8de342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":0.0886},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.2769},{"period":"6month","weight":-0.4123},{"period":"1year","weight":-0.2872},{"period":"ytd","weight":-0.3026}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcturus Therapeutics Holdings Inc.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.080132},{"month":2,"riseRate":0.545455,"avgChangeRate":0.011691},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.021161},{"month":4,"riseRate":0.545455,"avgChangeRate":0.101832},{"month":5,"riseRate":0.636364,"avgChangeRate":0.1056},{"month":6,"riseRate":0.583333,"avgChangeRate":0.023074},{"month":7,"riseRate":0.583333,"avgChangeRate":0.109538},{"month":8,"riseRate":0.5,"avgChangeRate":0.048962},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.078674},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.028789},{"month":11,"riseRate":0.636364,"avgChangeRate":0.065619},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.060891}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}